D.E. Shaw & Co’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,106,072
Closed -$4.52M 5236
2022
Q4
$4.52M Buy
5,106,072
+49,109
+1% +$65.1K 0.01% 2197
2022
Q3
$7.94M Sell
5,056,963
-824,439
-14% -$1.87M 0.01% 1574
2022
Q2
$11.8M Sell
5,881,402
-1,360,489
-19% -$2.35M 0.02% 1253
2022
Q1
$16.9M Buy
7,241,891
+4,794,841
+196% +$15M 0.02% 1153
2021
Q4
$11.4M Sell
2,447,050
-505,785
-17% -$3.14M 0.01% 1542
2021
Q3
$22.5M Buy
2,952,835
+1,142,466
+63% +$9.69M 0.03% 948
2021
Q2
$17.5M Buy
1,810,369
+1,415,064
+358% +$11.3M 0.02% 1094
2021
Q1
$3.27M Buy
395,305
+62,967
+19% +$665K ﹤0.01% 2172
2020
Q4
$2.27M Sell
332,338
-313,069
-49% -$2.51M ﹤0.01% 2479
2020
Q3
$7.2M Buy
645,407
+512,169
+384% +$4.69M 0.01% 1452
2020
Q2
$837K Sell
133,238
-69,281
-34% -$265K ﹤0.01% 3049
2020
Q1
$373K Sell
202,519
-373,626
-65% -$1.08M ﹤0.01% 3358
2019
Q4
$1.95M Buy
576,145
+503,174
+690% +$1.2M ﹤0.01% 2497
2019
Q3
$156K Buy
+72,971
New +$170K ﹤0.01% 3658
2019
Q2
Sell
-68,126
Closed -$324K 4009
2019
Q1
$324K Sell
68,126
-825,874
-92% -$2.17M ﹤0.01% 3194
2018
Q4
$2.15M Buy
894,000
+7,384
+0.8% +$24.1K ﹤0.01% 2099
2018
Q3
$3.9M Sell
886,616
-126,207
-12% -$700K 0.01% 1730
2018
Q2
$7.29M Buy
1,012,823
+309,451
+44% +$2.11M 0.01% 1280
2018
Q1
$3.62M Buy
703,372
+692,372
+6,294% +$4.93M 0.01% 1624
2017
Q4
$42K Buy
+11,000
New +$28.7K ﹤0.01% 3537
2015
Q4
Sell
-48,972
Closed -$411K 4051
2015
Q3
$411K Buy
+48,972
New +$780K ﹤0.01% 3186

Other funds holding SRNE